S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

ENVB Enveric Biosciences Inc

0.3325

-0.0345 (-9.40%)

Pre Market

Last Updated: 03:47:44

Delayed by 15 minutes

Form S-1 - General form for registration of securities under the Securities Act of 1933

Article too big to display. Click here to view on the SEC website

Enveric Biosciences (NASDAQ:ENVB)
Historical Stock Chart
From Dec 2024 to Jan 2025

Click Here for more Enveric Biosciences Charts.

Enveric Biosciences (NASDAQ:ENVB)
Historical Stock Chart
From Jan 2024 to Jan 2025

Click Here for more Enveric Biosciences Charts.

Enveric Biosciences Inc News

Form S-1 - General form for registration of securities under the Securities Act of 1933
Tuesday 14 January 2025 (12 hours ago) • Edgar (US Regulatory)

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
Monday 6 January 2025 (1 week ago) • Edgar (US Regulatory)

Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2025”
Monday 6 January 2025 (1 week ago) • Business Wire

Enveric Biosciences to Present at and Participate in Panel Discussion at Sachs Associates 8th Annual Neuroscience Innovation Forum During “J.P. Morgan Week 2025”
Monday 6 January 2025 (1 week ago) • Business Wire

Form DEF 14A - Other definitive proxy statements
Wednesday 18 December 2024 (4 weeks ago) • Edgar (US Regulatory)

Form PRER14A - Preliminary Proxy Soliciting materials
Thursday 12 December 2024 (1 month ago) • Edgar (US Regulatory)

Enveric Biosciences Announces New U.S. Patents Supporting EVM301 Series and EVM201 Series Compounds
Monday 2 December 2024 (1 month ago) • Business Wire

Form PRE 14A - Other preliminary proxy statements
Wednesday 27 November 2024 (2 months ago) • Edgar (US Regulatory)

Enveric Biosciences Preclinical Pharmacokinetic Studies of EB-003 Support Oral Bioavailability, Demonstrate Brain Penetration, and Show No Evidence of Hallucination-like Behavior
Monday 25 November 2024 (2 months ago) • Business Wire

Form 8-K - Current report
Friday 22 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 14 November 2024 (2 months ago) • Edgar (US Regulatory)

More Enveric Biosciences Inc News Articles

Sustainable Green Team (PK)

AMC Entertainment

Digital Brand Media and ... (PK)

Good Vibrations Shoes (PK)

Moon Equity (PK)

FuelCell Energy

Tonix Pharmaceuticals

Fannie Mae (QB)

Therapeutic Solutions (PK)

KULR Technology

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions